Suchergebnisse - "Xu, Tu"

PubPharm (35)

1

Marginal versus conditional rate estimation for count and recurrent event data with an estimand framework

enthalten in: Contemporary clinical trials | 2024

von Conner, S. | Zhou, Y. | Xu, T.

2

Conduction and validation of a novel prognostic signature in cervical cancer based on the necroptosis characteristic genes via integrating of multiomics data

enthalten in: Computers in biology and medicine | 2024

von Xu, T. | Jiang, J. | Xiang, X. | +4

3

Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR : A Phase 2 Placebo-controlled Clinical Trial

enthalten in: Annals of the American Thoracic Society | 2023

von Stahl, M. | Roehmel, J. | Eichinger, M. | +14

4

Effects of lumacaftor/ivacaftor on cystic fibrosis disease progression in children 2 through 5 years of age homozygous for F508del-CFTR : a phase 2 placebo-controlled clinical trial

enthalten in: Annals of the American Thoracic Society | Aug 2023

von Stahl, M. | Roehmel, J. | Eichinger, M. | +14

5

CpG-binding protein CFP1 promotes ovarian cancer cell proliferation by regulating BST2 transcription

enthalten in: Cancer gene therapy | 2022

von Yang, L. | Hu, H. | Han, Y. | +17

6

Morinda officinalis oligosaccharides mitigate chronic mild stress-induced inflammation and depression-like behaviour by deactivating the MyD88/PI3K pathway via E2F2

enthalten in: Frontiers in pharmacology | 2022

von Zhu, Z. | Yin, X. | Xu, T. | +8

7

Statistical considerations in clinical trial design with event-free survival as the primary efficacy endpoint

enthalten in: Pharmaceutical statistics | 2021

von Xu, T. | Zhang, Y. | Goldwasser, M. | +1

8

Statistical considerations in clinical trial design with event‐free survival as the primary efficacy endpoint

enthalten in: Pharmaceutical Statistics | 2021

von Xu, T. | Zhang, Y. | Goldwasser, M. | +1

9

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia : Results From a Phase Ib/II Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2019

von Wei, A. | Strickland, S. | Hou, J. | +17

CommentIn: J Clin Oncol. 2021 Sep 1;39(25):2742-2748. - PMID 34086506

10

An efficient sample size adaptation strategy with adjustment of randomization ratio

enthalten in: Biometrical journal. Biometrische Zeitschrift | 2019

von Wang, X. | Xu, T. | Zhong, S. | +2